These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31276155)

  • 1. Somatic PRKACA Mutations: Association With Transition From Pituitary-Dependent to Adrenal-Dependent Cushing Syndrome.
    Di Dalmazi G; Timmers HJLM; Arnaldi G; Küsters B; Scarpelli M; Bathon K; Calebiro D; Beuschlein F; Hermus A; Reincke M
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5651-5657. PubMed ID: 31276155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric study.
    Di Dalmazi G; Kisker C; Calebiro D; Mannelli M; Canu L; Arnaldi G; Quinkler M; Rayes N; Tabarin A; Laure Jullié M; Mantero F; Rubin B; Waldmann J; Bartsch DK; Pasquali R; Lohse M; Allolio B; Fassnacht M; Beuschlein F; Reincke M
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E2093-100. PubMed ID: 25057884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases.
    Thiel A; Reis AC; Haase M; Goh G; Schott M; Willenberg HS; Scholl UI
    Eur J Endocrinol; 2015 Jun; 172(6):677-85. PubMed ID: 25750087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase A defects and cortisol-producing adrenal tumors.
    Zilbermint M; Stratakis CA
    Curr Opin Endocrinol Diabetes Obes; 2015 Jun; 22(3):157-62. PubMed ID: 25871963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic mutations of the catalytic subunit of cyclic AMP-dependent protein kinase (PRKACA) gene in Japanese patients with several adrenal adenomas secreting cortisol [Rapid Communication].
    Nakajima Y; Okamura T; Gohko T; Satoh T; Hashimoto K; Shibusawa N; Ozawa A; Ishii S; Tomaru T; Horiguchi K; Okada S; Takata D; Rokutanda N; Horiguchi J; Tsushima Y; Oyama T; Takeyoshi I; Yamada M
    Endocr J; 2014; 61(8):825-32. PubMed ID: 25069672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Mutational Analysis of Cortisol-Producing Adenomas.
    Rege J; Hoxie J; Liu CJ; Cash MN; Luther JM; Gellert L; Turcu AF; Else T; Giordano TJ; Udager AM; Rainey WE; Nanba K
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e594-e603. PubMed ID: 34534321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRKACA Somatic Mutations Are Rare Findings in Aldosterone-Producing Adenomas.
    Rhayem Y; Perez-Rivas LG; Dietz A; Bathon K; Gebhard C; Riester A; Mauracher B; Gomez-Sanchez C; Eisenhofer G; Schwarzmayr T; Calebiro D; Strom TM; Reincke M; Beuschlein F
    J Clin Endocrinol Metab; 2016 Aug; 101(8):3010-7. PubMed ID: 27270477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome.
    Sato Y; Maekawa S; Ishii R; Sanada M; Morikawa T; Shiraishi Y; Yoshida K; Nagata Y; Sato-Otsubo A; Yoshizato T; Suzuki H; Shiozawa Y; Kataoka K; Kon A; Aoki K; Chiba K; Tanaka H; Kume H; Miyano S; Fukayama M; Nureki O; Homma Y; Ogawa S
    Science; 2014 May; 344(6186):917-20. PubMed ID: 24855271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cAMP signaling in cortisol-producing adrenal adenoma.
    Calebiro D; Di Dalmazi G; Bathon K; Ronchi CL; Beuschlein F
    Eur J Endocrinol; 2015 Oct; 173(4):M99-106. PubMed ID: 26139209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New insights in adrenal Cushing syndrome].
    Haissaguerre M; Tabarin A
    Ann Endocrinol (Paris); 2014 Oct; 75 Suppl 1():S37-45. PubMed ID: 25617921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline PRKACA amplification leads to Cushing syndrome caused by 3 adrenocortical pathologic phenotypes.
    Carney JA; Lyssikatos C; Lodish MB; Stratakis CA
    Hum Pathol; 2015 Jan; 46(1):40-9. PubMed ID: 25449630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome.
    Beuschlein F; Fassnacht M; Assié G; Calebiro D; Stratakis CA; Osswald A; Ronchi CL; Wieland T; Sbiera S; Faucz FR; Schaak K; Schmittfull A; Schwarzmayr T; Barreau O; Vezzosi D; Rizk-Rabin M; Zabel U; Szarek E; Salpea P; Forlino A; Vetro A; Zuffardi O; Kisker C; Diener S; Meitinger T; Lohse MJ; Reincke M; Bertherat J; Strom TM; Allolio B
    N Engl J Med; 2014 Mar; 370(11):1019-28. PubMed ID: 24571724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of PRKACA mutations in Chinese patients with adrenal lesions: a single-centre study.
    Li X; Wang B; Tang L; Lang B; Zhang Y; Zhang F; Chen L; Ouyang J; Zhang X
    Clin Endocrinol (Oxf); 2016 Dec; 85(6):954-961. PubMed ID: 27296931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of Aberrant PKA Activation by Cα Subunit Mutations.
    Calebiro D; Bathon K; Weigand I
    Horm Metab Res; 2017 Apr; 49(4):307-314. PubMed ID: 27813054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in Protein Kinase A Substrate Specificity as a Potential Cause of Cushing Syndrome.
    Bathon K; Weigand I; Vanselow JT; Ronchi CL; Sbiera S; Schlosser A; Fassnacht M; Calebiro D
    Endocrinology; 2019 Feb; 160(2):447-459. PubMed ID: 30615103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline PRKACA amplification causes variable phenotypes that may depend on the extent of the genomic defect: molecular mechanisms and clinical presentations.
    Lodish MB; Yuan B; Levy I; Braunstein GD; Lyssikatos C; Salpea P; Szarek E; Karageorgiadis AS; Belyavskaya E; Raygada M; Faucz FR; Izzat L; Brain C; Gardner J; Quezado M; Carney JA; Lupski JR; Stratakis CA
    Eur J Endocrinol; 2015 Jun; 172(6):803-11. PubMed ID: 25924874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRKACA: the catalytic subunit of protein kinase A and adrenocortical tumors.
    Berthon AS; Szarek E; Stratakis CA
    Front Cell Dev Biol; 2015; 3():26. PubMed ID: 26042218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A patient with recurrent hypercortisolism after removal of an ACTH-secreting pituitary adenoma due to an adrenal macronodule.
    Timmers HJ; van Ginneken EM; Wesseling P; Sweep CG; Hermus AR
    J Endocrinol Invest; 2006 Nov; 29(10):934-9. PubMed ID: 17185905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Illicit Upregulation of Serotonin Signaling Pathway in Adrenals of Patients With High Plasma or Intra-Adrenal ACTH Levels.
    Le Mestre J; Duparc C; Reznik Y; Bonnet-Serrano F; Touraine P; Chabre O; Young J; Suzuki M; Sibony M; Gobet F; Stratakis CA; Raverot G; Bertherat J; Lefebvre H; Louiset E
    J Clin Endocrinol Metab; 2019 Nov; 104(11):4967-4980. PubMed ID: 31074783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carney complex: an update.
    Correa R; Salpea P; Stratakis CA
    Eur J Endocrinol; 2015 Oct; 173(4):M85-97. PubMed ID: 26130139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.